BioSpace News Archive

Business

Astria Therapeutics to Report Third Quarter 2021 Financial Results and Recent Corporate Developments on Wednesday, November 10

Astria Therapeutics, Inc. will report third quarter 2021 financial results before the Nasdaq Global Market open on Wednesday, November 10, 2021.

October 27, 2021
·
1 min read
Biotech Bay

EBR Systems’ WiSE CRT System Demonstrates Technical Feasibility of Leadless Left Bundle Branch Area Pacing for Cardiac Resynchronization

EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced the publication of a case report demonstrating the WiSE™ CRT System’s ability to successfully deliver leadless Left Bundle Branch Area Pacing (LBBAP).

October 27, 2021
·
4 min read
Pharm Country

Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it is launching dexamethasone, 4mg and 6 mg, following Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA).

October 27, 2021
·
6 min read
Business

BYOMass Announces Appointment of Drs. Declan Doogan and Stephen Hoffman to Board of Directors

BYOMass, Inc., a biotech company developing selective TGF-β superfamily therapeutics, announced the appointment of Declan Doogan, M.D., and Stephen Hoffman, M.D., Ph.D., to the company’s Board of Directors.

October 27, 2021
·
3 min read
Drug Development

Kezar Announces First Patient Dosed in Phase 1 Trial of KZR-261 in Advanced Solid Tumor Malignancies

Kezar Life Sciences, Inc. today announced that the first patient has been dosed in KZR-261-101, a Phase 1 clinical trial evaluating KZR-261, a novel, broad-spectrum, anti-tumor agent that acts through direct interaction and inhibition of the Sec61 translocon.

October 27, 2021
·
5 min read
Genetown

Rheos Medicines Forms Research Collaboration With CRYOSTEM to Evaluate MALT1‑Targeted Therapeutics for Graft-versus-Host-Disease

Rheos Medicines, a biopharmaceutical company bringing molecular targeting and precision treatment to autoimmune and inflammatory disease, today announced a research collaboration with the French non-profit research organization CRYOSTEM.

October 27, 2021
·
7 min read
BioMidwest

Forge Biologics to Present at Jefferies Gene Therapy / Editing Summit

Forge Biologics announced today that Timothy J. Miller, Ph.D., Forge’s CEO, President, and Co-Founder, will deliver a company presentation at the Jefferies Gene Therapy / Editing Summit on Thursday, October 28, at 12:30 p.m. ET.

October 27, 2021
·
2 min read
Biotech Beach

Fulgent Genetics Launches At-Home Neutralizing Antibody Test for COVID-19

Fulgent Genetics, Inc. today announced that it has launched an antibody test for COVID-19 which will specifically target neutralizing antibodies.

October 27, 2021
·
7 min read
Business

Boehringer Ingelheim and King’s College London Join Forces to Progress New Therapeutic Concepts in Major Depressive Disorder and Schizophrenia

Together, Boehringer Ingelheim and King’s College London today announced a new collaboration focused on understanding the malfunctions in brain circuits that drive impaired cognition in people with major depressive disorder (MDD) and schizophrenia (SZ).

October 27, 2021
·
4 min read
Pharm Country

Bayer to present new analyses adding to the depth of knowledge on the cardiovascular and renal outcomes of KERENDIA® (finerenone)

Bayer to present new analyses adding to the depth of knowledge on the cardiovascular and renal outcomes of KERENDIA ® (finerenone)

October 27, 2021
·
13 min read